Takeda Pharmaceuticals and Lundbeck have jointly announced the submission of a New Drug Application (NDA ... is under investigation as an antidepressant for the treatment of major depressive ...
The market for antidepressants is, however, getting more competitive after years of stagnation, with a string of new drugs on or approaching the market including AbbVie’s Vraylar (cariprazine ...
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that ...
Antidepressants are medications that help treat symptoms of depression. Most impact a type of chemical called a neurotransmitter. Neurotransmitters carry messages between the cells in your brain.
a partial response and an unbearable side effect have been reported following the same conventional drug dosing, which may affect the treatment adherence. Because tricyclic antidepressants and ...
Drugmakers set drug prices not out of pure greed but to ensure they can recoup the $2.6 billion and the decade-plus it costs on average to develop a single new drug. They also need to compensate ...